Literature DB >> 9094170

Intraductal papillary-mucinous neoplasm of the pancreas: a report of five cases with immunohistochemical findings.

J G Kench1, R P Eckstein, R C Smith.   

Abstract

Five cases of intraductal papillary-mucinous neoplasm (IPMN) of the pancreas are here described. This group of tumors represents a distinct clinicopathological entity with characteristic endoscopic, radiological, gross and microscopic appearances. Our five cases all showed marked dilatation of the main pancreatic duct which contained mucin and papillary tumor, sometimes filling and sometimes lining the lumen. The papillae were lined by columnar epithelium showing varying degrees of dysplasia. In one case there was adjacent invasive adenocarcinoma. Immunohistochemical staining for p53 protein was strongly positive in a majority of cells in the three cases with severe epithelial dysplasia and in the invasive adenocarcinoma, while weaker staining in a minority of cells was seen in the remaining two cases. A small proportion of tumor cells expressed PCNA and Ki-67 immunohistochemically in four cases, while the case with severe dysplasia and invasive carcinoma showed positivity for these proliferation markers in most cells. The four cases of exclusively intraductal tumor showed no evidence of disease recurrence at follow-up (median 55 months). The patient with IPMN and associated invasive adenocarcinoma died 21 months post-operatively. In view of its relatively favourable prognosis, it is important that IPMN is recognised.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094170     DOI: 10.1080/00313029700169454

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  5 in total

1.  Intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Jose G Trevino; N Joseph Espat; W Scott Helton
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

2.  Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.

Authors:  T A Sohn; C J Yeo; J L Cameron; C A Iacobuzio-Donahue; R H Hruban; K D Lillemoe
Journal:  Ann Surg       Date:  2001-09       Impact factor: 12.969

3.  Aberrant p16(INK4A) and DPC4/Smad4 expression in intraductal papillary mucinous tumours of the pancreas is associated with invasive ductal adenocarcinoma.

Authors:  A V Biankin; S A Biankin; J G Kench; A L Morey; C-S Lee; D R Head; R P Eckstein; T B Hugh; S M Henshall; R L Sutherland
Journal:  Gut       Date:  2002-06       Impact factor: 23.059

4.  Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas.

Authors:  Yuichi Kitagawa; Trisha A Unger; Shari Taylor; Richard A Kozarek; L William Traverso
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 5.  Intraductal papillary mucinous neoplasm of the pancreas: an update.

Authors:  Shu-Yuan Xiao
Journal:  Scientifica (Cairo)       Date:  2012-11-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.